TY - GEN
T1 - Acetyl-l-carnitine reduces the infarct size and striatal glutamate outflow following focal cerebral ischemia in rats
AU - Jalal, Fakhreya Yousuf
AU - Böhlke, Mark
AU - Maher, Timothy J.
PY - 2010/6
Y1 - 2010/6
N2 - Acetyl-l-carnitine (ALCAR), an endogenous water soluble molecule, is synthesized in the brain and is involved in many aspects of neuronal activity, including metabolism and neuronal membrane formation and integrity. To determine ALCAR's neuroprotective effects, focal cerebral ischemia was induced using four models of middle cerebral artery occlusion (MCAO) and treatment with 0-400 mgkg ALCAR (i.p.) prior to MCAO. While acute doses were without effect, pretreatment with chronic ALCAR (400 mgkgday for five days) significantly reduced infarct size. Lower chronic ALCAR doses were not effective. Additionally, elevations in microdialysate glutamate post-MCAO were attenuated by ALCAR treatment.
AB - Acetyl-l-carnitine (ALCAR), an endogenous water soluble molecule, is synthesized in the brain and is involved in many aspects of neuronal activity, including metabolism and neuronal membrane formation and integrity. To determine ALCAR's neuroprotective effects, focal cerebral ischemia was induced using four models of middle cerebral artery occlusion (MCAO) and treatment with 0-400 mgkg ALCAR (i.p.) prior to MCAO. While acute doses were without effect, pretreatment with chronic ALCAR (400 mgkgday for five days) significantly reduced infarct size. Lower chronic ALCAR doses were not effective. Additionally, elevations in microdialysate glutamate post-MCAO were attenuated by ALCAR treatment.
KW - ALCAR
KW - cerebral ischemia
KW - glutamate
KW - infarct size
KW - microdialysis
KW - stroke
UR - http://www.scopus.com/inward/record.url?scp=77953992146&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=77953992146&partnerID=8YFLogxK
U2 - 10.1111/j.1749-6632.2009.05351.x
DO - 10.1111/j.1749-6632.2009.05351.x
M3 - Conference contribution
C2 - 20633114
AN - SCOPUS:77953992146
SN - 9781573317771
T3 - Annals of the New York Academy of Sciences
SP - 95
EP - 104
BT - Neuroprotective Agents
PB - Blackwell Publishing Inc.
ER -